These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24831943)

  • 1. Epstein-Barr virus and risk of non-Hodgkin lymphoma in the cancer prevention study-II and a meta-analysis of serologic studies.
    Teras LR; Rollison DE; Pawlita M; Michel A; Brozy J; de Sanjose S; Blase JL; Gapstur SM
    Int J Cancer; 2015 Jan; 136(1):108-16. PubMed ID: 24831943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma.
    Bertrand KA; Birmann BM; Chang ET; Spiegelman D; Aster JC; Zhang SM; Laden F
    Blood; 2010 Nov; 116(18):3547-53. PubMed ID: 20647565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between non-Hodgkin's lymphoma and blood levels of Epstein-Barr virus in children in north-western Tanzania: a case control study.
    Kabyemera R; Masalu N; Rambau P; Kamugisha E; Kidenya B; De Rossi A; Petrara MR; Mwizamuholya D
    BMC Pediatr; 2013 Jan; 13():4. PubMed ID: 23294539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus viral load and serology in childhood non-Hodgkin's lymphoma and chronic inflammatory conditions in Uganda: implications for disease risk and characteristics.
    Orem J; Sandin S; Mbidde E; Mangen FW; Middeldorp J; Weiderpass E
    J Med Virol; 2014 Oct; 86(10):1796-803. PubMed ID: 24889739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of epstein-barr virus as a potential cause of B-cell non-Hodgkin lymphoma in a prospective cohort.
    De Roos AJ; Martínez-Maza O; Jerome KR; Mirick DK; Kopecky KJ; Madeleine MM; Magpantay L; Edlefsen KL; Lacroix AZ
    Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1747-55. PubMed ID: 23885038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus infection and risk of lymphoma: immunoblot analysis of antibody responses against EBV-related proteins in a large series of lymphoma subjects and matched controls.
    de Sanjosé S; Bosch R; Schouten T; Verkuijlen S; Nieters A; Foretova L; Maynadié M; Cocco PL; Staines A; Becker N; Brennan P; Benavente Y; Boffetta P; Meijer CJ; Middeldorp JM
    Int J Cancer; 2007 Oct; 121(8):1806-12. PubMed ID: 17557295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas.
    Hamilton-Dutoit SJ; Pallesen G
    Am J Pathol; 1992 Jun; 140(6):1315-25. PubMed ID: 1318639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection.
    Feng YF; Wu QL; Zong YS
    Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
    Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
    J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association between the Comprehensive Epstein-Barr Virus Serologic Profile and Endemic Burkitt Lymphoma.
    Coghill AE; Proietti C; Liu Z; Krause L; Bethony J; Prokunina-Olsson L; Obajemu A; Nkrumah F; Biggar RJ; Bhatia K; Hildesheim A; Doolan DL; Mbulaiteye SM
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):57-62. PubMed ID: 31619404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of organohalogen compounds and titres of antibodies to Epstein-Barr virus antigens and the risk for non-Hodgkin lymphoma.
    Hardell K; Carlberg M; Hardell L; Björnfoth H; Ericson Jogsten I; Eriksson M; Van Bavel B; Lindström G
    Oncol Rep; 2009 Jun; 21(6):1567-76. PubMed ID: 19424638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus (EBV) antibodies in children with non-Hodgkin's lymphomas.
    Roubalová K; Weinreb M; Roubal J; Kodet R; Koutecký J; Vonka V
    Acta Virol; 1988 Jul; 32(4):339-48. PubMed ID: 2903639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated antibody levels to Epstein-Bbarr virus antigens in patients with hairy cell leukemia compared to controls in relation to exposure to pesticides, organic solvents, animals, and exhausts.
    Nordström M; Hardell L; Linde A; Schloss L; Näsman A
    Oncol Res; 1999; 11(11-12):539-44. PubMed ID: 10905566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma.
    Levin LI; Chang ET; Ambinder RF; Lennette ET; Rubertone MV; Mann RB; Borowitz M; Weir EG; Abbondanzo SL; Mueller NE
    Blood; 2012 Nov; 120(18):3750-5. PubMed ID: 22972983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Antibodies against Epstein-Barr Virus (EBV) and p53 in EBV-Positive and -Negative Gastric Cancer.
    Camargo MC; Kim KM; Matsuo K; Torres J; Liao LM; Morgan D; Michel A; Waterboer T; Song M; Gulley ML; Dominguez RL; Yatabe Y; Kim S; Cortes-Martinez G; Lissowska J; Zabaleta J; Pawlita M; Rabkin CS
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):414-419. PubMed ID: 31719065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein Barr virus (EBV) carrying cells in blood of Hodgkin's disease (HD) and non-Hodgkin lymphoma (NHL) patients with high antibody titers against EBV capsid antigens (VCA).
    Lewin N; Aman P; Mellstedt H; Carenfelt C; Klein G; Klein E
    Anticancer Res; 1990; 10(5A):1213-6. PubMed ID: 2173472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients.
    Masucci G; Mellstedt H; Henle G; Henle W; Rymo L; Masucci MG; Ernberg I; Klein G
    Int J Cancer; 1989 Jun; 43(6):1017-21. PubMed ID: 2543639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma.
    Bonnet F; Jouvencel AC; Parrens M; Leon MJ; Cotto E; Garrigue I; Morlat P; Beylot J; Fleury H; Lafon ME
    J Clin Virol; 2006 Aug; 36(4):258-63. PubMed ID: 16762591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.